Skip to main content
          Skip to FDA Search
          Skip to in this section menu
          Skip to footer links


U.S. flagAn official website of the United States government

					Here’s how you know
          			Dot gov**The .gov means it’s official.**Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
							      SSL**The site is secure.** The **https://** ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely. 
			U.S. Food and Drug Administration
				
        Search
            Menu
							
						Search FDA
									
									Submit search 
		Featured
							Contact FDA
	                FDA Guidance Documents
	                Recalls, Market Withdrawals and Safety Alerts
	                Press Announcements
	                Warning Letters
	                Advisory Committees
	                En Español

					Products
            Food
							Drugs
							Medical Devices
							Radiation-Emitting Products
							Vaccines, Blood, and Biologics
							Animal and Veterinary
							Cosmetics
							Tobacco ProductsTopics
            About FDA
							Combination Products
							Regulatory Information
							Safety
							Emergency Preparedness
							International Programs
							News and Events
							Training and Continuing Education
							Inspections and Compliance
							Science and ResearchInformation For
            Consumers
	            Patients
	            Industry
	            Health Professionals
	            Federal, State and Local Officials 
 In this section:

                Combination Products

Combination Products

                        


                        About Combination Products
          Combination Products Meetings, Conferences, & Workshops
          Feedback on Combination Products
          Guidance & Regulatory Information
          Jurisdictional Information
          RFD Process Home
          Combination Products
          FAERS Example Scenario.  NDA-approved prefilled on-body infusorCombination Products FAERS Example Scenario.  NDA-approved prefilled on-body infusor
  
  	
    Share
    Post
    Linkedin

    Email
    PrintThe following scenario is intended solely to illustrate how to provide combination product information identified in section V.B.2 of the Postmarketing Safety Reporting for Combination Products Guidance for Industry and FDA Staffin the data fields of the FAERS reporting system. The scenario described below is not intended to provide a comprehensive representation of all information that may be appropriate to include in ICSRs or how to present it, for a given event, report type, or product type, nor to identify all reports that may be required in relation to the events described.

**Scenario.** The Combination Product Applicant for an NDA-approved (NDA 123456) prefilled on-body infusor receives information on an event that only involved a reportable malfunction (see 21 CFR 4.102(c) and 803.50). The malfunction was reported by a nurse at XYZ General Hospital and involved a software problem where a dose was missed because the on-body infusor indicated that a dose had been administered when, in fact, no dose was administered. The on-body infusor is prefilled with the drug product, Drug A, which contains the active ingredient, Active A. The infusor is branded as Infusor A.

**Data Elements.**The Combination Product Applicant searches the Device Product Classification Database, but does not find any product codes that align with the on-body infusor and therefore does not include the procode but does provide a device common name.

The Combination Product Applicant reviews the Device Problem Codes and identifies “Medication Error FDA 3198; C91396 Event in which the device software design results in errors of medication preparation or administration” as appropriate for the malfunction.

Because this was a malfunction-only event, there was no adverse patient reaction. Therefore, the Combination Product Applicant does not identify an adverse patient reaction and uses “None” for patient identifier and “No Adverse Event”  in the adverse event coding.

In addition to other appropriate content for the Malfunction report type, the Combination Product Applicant completes the following elements in the ICSR data fields for FAERS as indicated below:

Type of Information
			(see section V.B.2 of the PMSR guidance)
			Data Element
			DTD Descriptor
			Element ValueCombination Product Report Identifier
			A.1.FDA.15
			<combinationproductreport>
			1 = YesReport Type(s) A.1.9
			A.1.9
			<fulfillexpeditecriteria>
			5 = 30-DayB.4.k.20.FDA.17
			<malfunction>
			1 = YesPatient Identifier
			B.1.1
			<patientinitial>
			NoneReporter Identifier 1
			A.2.1.2a
			<reporterorganization>
			XYZ General HospitalA.2.1.4
			<qualification>
			3 = Other Health ProfessionalSuspect Medical Device and Device Problem Code
			B.4.k.20.FDA.1
			<brandname>
			Infusor AB.4.k.20.FDA.2
			<commondevicename>
			On-body InfusorB.4.k.20.FDA.3
			<productcode>
			[blank]B.4.k.20.FDA.17
			<malfunction>
			1 = YesB.4.k.18.6.FDA.19.1a
			<evaluation type>
			01 = Device ProblemB.4.k.18.6.FDA.19.1b
			<evaluationvalue>
			3198Suspect Drug Product
			B.4.k.2.1
			<medicinalproduct>
			Drug AB.4.k.2.2
			<activesubstancename>
			Active AB.4.k.4.1
			<drugauthorizationnumb>
			NDA 123456Adverse Event Coding
			B.2.i.0
			<primarysourcereaction>
			No Adverse Event



1 Identify the reporter using the following data element(s) as applicable and known:  Reporter title (A.2.1.1a <reportertitle>), Reporter given name (A.2.1.1b <reportergivename>), Reporter middle name (A.2.1.1c <reportermiddlename>), Reporter family name (A.2.1.1d <reporterfamilyname>), Reporter organization (A.2.1.2a <reporterorganization>), Reporter department (A.2.1.2b <reporterdepartment>), Reporter street (A.2.1.2c <reporterstreet>), Reporter city (A.2.1.2d <reportercity>), Reporter state or province (A.2.1.2e <reporterstate>), Reporter postcode (A.2.1.2f <reporterpostcode>), Reporter country code (A.2.1.3 <reportercountry>).

                                                                                  Content current as of:
      06/25/2019Combination Products

          
                        


                        About Combination Products
          Combination Products Meetings, Conferences, & Workshops
          Feedback on Combination Products
          Guidance & Regulatory Information
          Jurisdictional Information
          RFD Process
 
 Footer Links
    FDA Archive
          About FDA
          Accessibility
      Visitor Information
          Website Policies / Privacy
          No FEAR Act
          Vulnerability Disclosure Policy
      FOIA
          HHS.gov
          USA.gov
    Contact FDA
      Follow FDA on Facebook
      Follow FDA on X
      Follow FDA on Instagram
      Follow FDA on LinkedIn
      View FDA videos on YouTube
      Subscribe to FDA RSS feeds
    FDA Homepage
    Contact Number
      1-888-INFO-FDA (1-888-463-6332) Back toTop